Forum

Forum Navigation
You need to log in to create posts and topics.

US FDA looks to advance use of DHTs in drug trials

Seeking to increase their understanding of the opportunities and challenges of using digital health technologies (DHTs) in drug trials, the U.S. FDA’s CBER and CDER are requesting public feedback to help inform new guidance as the technologies continue to advance.

Scroll to Top